Insulet Corporation
https://www.insulet.com/
Already a Biomedtracker subscriber?
You have access to the full company record through your subscription
Want to become a subscriber?
Subscribers get more company details, updates, company financials and company products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Insulet Corporation
Exec Chat: How Glooko Plans To Ride Digital Health Care Wave To Profitability
In an interview with Medtech Insight, Glooko CEO Russ Johannesson outlines the company’s growth opportunities, expansion plans beyond diabetes and financing plans.
Lilly Tries New Neuro Approach With Disarm Buyout
Deal Snapshot: Lilly bets $135m on biotech’s preclinical SARM1 inhibitor program, seeing potential in peripheral neuropathy and possibly some bigger targets in neurology like MS and ALS.
Insulin Pump Market Heats Up Among Rivals Medtronic, Insulet and Tandem
Three major insulin pump developers are gearing up to introduce next-generation devices over the coming year, but COVID-19 continues to create uncertainties.
Roche Partners With UCB On Anti-Tau Alzheimer’s Drug
UCB gets $120m up front from Roche for option rights to UCB0107 and retains full rights to the drug in progressive supranuclear palsy.
Company Information
- Industry
- Medical Devices
- Other Names / Subsidiaries
-
- Insulet Canada Corporation
- Neighborhood Diabetes
- Neighborhood Holdings, Inc.